Salvadora persica L. chewing stick and standard toothbrush as anti-plaque and anti-gingivitis tool: A systematic review and meta-analysis

被引:9
|
作者
Adam, Fara Azwin [1 ,2 ]
Mohd, Nurulhuda [1 ]
Rani, Haslina [3 ]
Baharin, Badiah [1 ]
Yusof, Mohd Yusmiaidil Putera Mohd [4 ,5 ]
机构
[1] Univ Kebangsaan Malaysia, Fac Dent, Dept Restorat Dent, Unit Periodontol, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300, Malaysia
[2] Fac Dent Univ Teknol MARA, Ctr Periodontol Studies, Sungai Buloh 47000, Selangor, Malaysia
[3] Univ Kebangsaan Malaysia, Fac Dent, Dept Family Oral Hlth, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300, Malaysia
[4] Univ Teknol MARA, Ctr Oral & Maxillofacial Diagnost & Med Studies, Fac Dent, Sungai Buloh 47000, Selangor, Malaysia
[5] Univ Teknol MARA, Inst Pathol, Lab & Forens Med I PPerForM, Sungai Buloh 47000, Selangor, Malaysia
关键词
Natural toothbrush; Miswak; Oral biofilm; Periodontal diseases; Oral hygiene tool; PERIODONTAL-DISEASE; DENTAL PLAQUE; MISWAK; PLANT; EXTRACTS;
D O I
10.1016/j.jep.2021.113882
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Salvadora persica L. chewing stick, commonly known as miswak is still being used as an oral hygiene tool for plaque control and prevention against gingivitis. Various studies have reported on the therapeutics and prophylactic effects particularly on periodontal disease. This review aimed to evaluate the effectiveness of S. persica chewing stick compared to the standard toothbrush for anti-plaque and anti-gingivitis. Material and methods: A PRISMA-compliant systematic search of literature was done from the MEDLINE, CENTRAL, Science Direct, PubMed and Google Scholar. Literature that fulfilled eligibility criteria was identified. Data measuring plaque score and bleeding score were extracted. Qualitative and random-effects meta-analyses were conducted. Results: From 1736 titles and abstracts screened, eight articles were utilized for qualitative analysis, while five were selected for meta-analysis. The pooled effect estimates of SMD and 95% CI were -0.07 [-0.60 to 0.45] with an chi(2) statistic of 0.32 (p = 0.0001), I-2 = 80% as anti-plaque function and 95% CI were -2.07 [-4.05 to -0.10] with an chi(2) statistic of 1.67 (p = 0.02), I-2 = 82%. Conclusion: S. persica chewing stick is a tool that could control plaque, comparable to a standard toothbrush. Further, it has a better anti-gingivitis effect and can be used as an alternative.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Safety and Efficacy of Anti-PD-1/PD-L1 Inhibitors Compared With Docetaxel for NSCLC: A Systematic Review and Meta-Analysis
    Ma, Long
    Jin, Gang
    Yao, Keying
    Yang, Yi
    Chang, Ruitong
    Wang, Wenhao
    Liu, Jiawei
    Zhu, Zijiang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [22] The effects of L-carnitine supplementation on inflammatory and anti-inflammatory markers in adults: a systematic review and dose-response meta-analysis
    Rastgoo, Samira
    Fateh, Sahand Tehrani
    Nikbaf-Shandiz, Mahlagha
    Rasaei, Niloufar
    Aali, Yasaman
    Zamani, Mohammad
    Shiraseb, Farideh
    Asbaghi, Omid
    INFLAMMOPHARMACOLOGY, 2023, 31 (05) : 2173 - 2199
  • [23] The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/PD-L1 plus anti-CTLA-4): a systematic review and meta-analysis
    Gu, Lihu
    Khadaroo, Parikshit Asutosh
    Su, Hui
    Kong, Liya
    Chen, Liangliang
    Wang, Xianfa
    Li, Xinlong
    Zhu, Hepan
    Zhong, Xin
    Pan, Junhai
    Chen, Manman
    BMC CANCER, 2019, 19 (1)
  • [24] The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/PD-L1 plus anti-CTLA-4): a systematic review and meta-analysis
    Lihu Gu
    Parikshit Asutosh Khadaroo
    Hui Su
    Liya Kong
    Liangliang Chen
    Xianfa Wang
    Xinlong Li
    Hepan Zhu
    Xin Zhong
    Junhai Pan
    Manman Chen
    BMC Cancer, 19
  • [25] Anti-Tumor Efficacy of Anti-PD-1/PD-L1 Antibodies in Combination With Other Anticancer Drugs in Solid Tumors: A Systematic Review and Meta-Analysis
    Inoue, Takashi
    Narukawa, Mamoru
    CANCER CONTROL, 2022, 29
  • [26] Efficacy and safety of anti-PD-1/PD-L1 combinations versus standard of care in cancer: a systematic review and meta-analysis.
    Carretero-Gonzalez, Alberto
    Otero, Irene
    Lora, David
    Carril-Ajuria, Lucia
    Castellano, Daniel
    de Velasco, Guillermo
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [27] Is Therapeutic Drug Monitoring for Anti-tumour Necrosis Factor Agents in Adults With Inflammatory Bowel Disease Ready for Standard of Care? A Systematic Review and Meta-analysis
    Shah, Raj
    Hoffman, Gila R.
    El-Dallal, Mohammed
    Goldowsky, Alexander M.
    Chen, Ye
    Feuerstein, Joseph D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (08): : 1057 - 1065
  • [28] PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis
    Gandini, Sara
    Massi, Daniela
    Mandala, Mario
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 100 : 88 - 98
  • [29] Nephrotoxicity in patients with solid tumors treated with anti-PD-1/PD-L1 monoclonal antibodies: a systematic review and meta-analysis
    Li, Han
    Xu, Jinsheng
    Bai, Yaling
    Zhang, Shenglei
    Cheng, Meijuan
    Jin, Jingjing
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (03) : 860 - 870
  • [30] Nephrotoxicity in patients with solid tumors treated with anti-PD-1/PD-L1 monoclonal antibodies: a systematic review and meta-analysis
    Han Li
    Jinsheng Xu
    Yaling Bai
    Shenglei Zhang
    Meijuan Cheng
    Jingjing Jin
    Investigational New Drugs, 2021, 39 : 860 - 870